Exercise perspective: Benefits and mechanisms of gut microbiota on the body
- PMID: 39019779
- PMCID: PMC11255194
- DOI: 10.11817/j.issn.1672-7347.2024.230550
Exercise perspective: Benefits and mechanisms of gut microbiota on the body
Abstract
Gut microbiota refers to the vast and diverse community of microorganisms residing in the intestines. Factors such as genetics, environmental influences (e.g., exercise, diet), and early life experiences (e.g., infant feeding methods) can all affect the ecological balance of gut microbiota within the body. Dysbiosis of the gut microbiota is associated with extra-intestinal diseases such as Parkinson's syndrome, osteoporosis, and autoimmune diseases, suggesting that disturbances in gut microbiota may be one of the causes of these diseases. Exercise benefits various diseases, with gut microbiota playing a role in regulating the nervous, musculoskeletal, and immune systems. Gut microbiota can impact the body's health status through the gut-brain axis, gut-muscle axis, and immune pathways. Moderate-intensity aerobic exercise can increase the quantity of gut microbiota and change microbial abundance, although short-term exercise does not significantly affect the alpha diversity of the microbiota. Resistance exercise also does not have a significant regulatory effect on gut microbiota.
肠道菌群是指寄居在肠道内数量庞大、种类繁多的微生物群。遗传、环境因素(如运动、饮食)和早期生活(如婴儿期的喂养方式)等均可影响肠道菌群在机体内的生态平衡。肠道生态失调与肠外疾病(如帕金森综合征、骨质疏松、自身免疫性疾病等)相关,故肠道菌群的紊乱可能是这些疾病发病的原因之一。运动对多种疾病有益处,肠道菌群参与神经系统、运动系统、免疫系统的调控。肠道菌群可以通过肠-脑轴、肠-肌轴、免疫等途径影响机体的健康状态;中等强度的有氧运动可以增加肠道菌群的数量,改变菌群丰度,但短期运动对菌群的α多样性无明显影响,抗阻运动对于肠道菌群亦无明显的调控作用。.
Keywords: dysbiosis; ecological balance; exercise; gut microbiota; metabolites.
Conflict of interest statement
作者声称无任何利益冲突。
Figures


Similar articles
-
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.Ageing Res Rev. 2018 Aug;45:53-61. doi: 10.1016/j.arr.2018.04.004. Epub 2018 Apr 26. Ageing Res Rev. 2018. PMID: 29705121 Review.
-
The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.Brain. 2021 Oct 22;144(9):2571-2593. doi: 10.1093/brain/awab156. Brain. 2021. PMID: 33856024 Review.
-
The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson's disease.Neurol Sci. 2025 Feb;46(2):561-578. doi: 10.1007/s10072-024-07878-x. Epub 2024 Nov 15. Neurol Sci. 2025. PMID: 39546084 Free PMC article. Review.
-
Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases.Mol Neurobiol. 2024 Dec;61(12):9873-9891. doi: 10.1007/s12035-023-03691-3. Epub 2023 Oct 18. Mol Neurobiol. 2024. PMID: 37851313 Review.
-
Gut brain axis: an insight into microbiota role in Parkinson's disease.Metab Brain Dis. 2021 Oct;36(7):1545-1557. doi: 10.1007/s11011-021-00808-2. Epub 2021 Aug 9. Metab Brain Dis. 2021. PMID: 34370175 Review.
Cited by
-
BTVT ameliorates offspring blood-brain barrier damage induced by prenatal and lactational neodymium oxide exposure via the gut-brain axis.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Apr 28;50(4):615-624. doi: 10.11817/j.issn.1672-7347.2025.250173. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40785675 Free PMC article. Chinese, English.
-
The Role of G Protein-Coupled Receptors in the Regulation of Orthopaedic Diseases by Gut Microbiota.Nutrients. 2025 May 16;17(10):1702. doi: 10.3390/nu17101702. Nutrients. 2025. PMID: 40431441 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical